Back in 2018 as the whole world celebrated the advances in AI technologies, nobody expected the next healthcare revolution to come so soon.
The current global pandemic accelerated the necessity for online healthcare solutions to help mediate the outbreak and tackle major clinical issues. New technologies stepped in, transforming digital health products and leading the fight against COVID-19.
In times of crisis, it’s more important than ever for entrepreneurs and technologists to come together, to share knowledge and exchange ideas as to how we can support one another.
To strengthen our ties with the Ruhrgebiet’s bustling startup scene, we’ve partnered up with ruhr:HUB, Digital Campus Zollverein, Inititiativkreis Ruhr, Business Metropole Ruhr, Gründerallianz Ruhr and RAG Stiftung to create a 3-month program for startups in the field of digital health and provide all the necessary tools to scale MedTech businesses.
Get to know the first cohort of our Building Bridges program, who are leading the digitization of the German Healthcare industry:
Introducing the 5 selected digital health startups who will join the #BuildingBridges program and spend 3 months under the mentorship of ruhr:LAB and #FactoryBerlin.@RuhrHub@irgmbh@business_ruhr@RagStiftung@Gruenderallianz
Stay tuned for more updates. pic.twitter.com/nd0UwrVKy2
— Factory Berlin (@FactoryBerlin) June 11, 2020
Intrepida’s AI tool Ancora makes finding the right trial effortless. The platform plays in the clinical research space, allowing patients to look for relevant clinical trials and track the latest advances. With patients being the main focus and AI as an engine, Ancora.ai helps to reduce the time-consuming process of finding participants, as well as remove the patient’s task of weeding through complex medical terminology by providing them with a simple questionnaire instead. The tool now supports the search for COVID-19 clinical trials to help develop treatments and diagnostics for the urgent fight against the pandemic.
With the aim of becoming the go-to company when it comes to Cancer treatments, Remissio uses AI to target the main mechanism behind immunotherapies by understanding the conditions for protein interactions. By predicting the activity of the therapy, Remissio are able to provide their customers with the list of possible side effects, including high-quality experimental evidence.
With a revolutionary AI-powered diagnostic system Allergoscope optimizes performance by offering unprecedented accuracy when it comes to diagnosing allergies. AllergoScope helps to avoid conventional and often inaccurate provocation tests, which can cause additional side effects. Based on the improved CPT test, automatic eye-detection uses deep-learning algorithms and monitors the development of any inflammatory reactions in the eye.
Tackling major problems in elderly care, Visseiro allows the switch from hospital-centred sick care systems to a community based and integrated health care system.
Based on the insights of elderly behavior, Visseiro came up with a solution to create a Smart Senior Seat Cushion which provides daily updates on a patient’s state of health (Heart, respiration & etc) with servers connected to doctors and nurses. Integrated sensors help to collect tremendous amounts of data and provide efficient treatment while improving quality of care.
Using Digital Therapeutics, VILA Health focuses on chronic disease patients with a risk of developing psychological disorders. Based on the valid psychological methods of cognitive behavioural therapy and acceptance and commitment therapy, the flexible app provides them with important methods, tools and tips for dealing with the specific topics and challenges related to their chronic illness.